Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (now SciSparc Ltd.) covers the month of January 2021, with a specific report date of January 28, 2021. The filing serves to announce a corporate name change from Therapix Biosciences Ltd. to SciSparc Ltd.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a name change and does not contain financial statements or performance data.
Material Changes
- Corporate Name Change: The Company officially changed its name from Therapix Biosciences Ltd. to SciSparc Ltd. as announced in a press release dated January 28, 2021.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items beyond the administrative name change.
Key Facts for Investor Verification
- Verify the legal effectiveness of the name change to SciSparc Ltd. in relevant jurisdictions.
- Confirm the updated ticker symbol and trading status on the stock exchange following the name change.
- Review the attached press release (Exhibit 99.1) for any strategic rationale behind the rebranding not detailed in the Form 6-K summary.